GD Pediatrics: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GD Pediatrics
Largest movements
- Cash +€279
up €279 (+1.1%), from €25,020 to €25,299
mainly Net result for the year (+€1,929)
- Profit (loss) carried forward +€1,929
up €1,929 (+188.9%), from €1,021 to €2,950
- Other debts -€1,650
down €1,650 (-7.2%), from €22,999 to €21,349
- Gross operating margin +€21,701
up €21,701, from -€14,693 to €7,008
- Taxes +€3,831
new in 2025: €3,831
- Staff costs +€275
new in 2025: €275
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €25,020 | €25,299 | +€279 | +1.1% |
| Current assets | 29/58 | €25,020 | €25,299 | +€279 | +1.1% |
| Cash at bank and in hand | 54/58 | €25,020 | €25,299 | +€279 | +1.1% |
| Total equity and liabilities | 10/49 | €25,020 | €25,299 | +€279 | +1.1% |
| Equity | 10/15 | €2,021 | €3,950 | +€1,929 | +95.4% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Outside capital | 11 | €1,000 | - | -€1,000 | |
| Share premium | 1100/10 | €1,000 | - | -€1,000 | |
| Profit (loss) carried forward | 14 | €1,021 | €2,950 | +€1,929 | +188.9% |
| Amounts payable | 17/49 | €22,999 | €21,349 | -€1,650 | -7.2% |
| Amounts payable within one year | 42/48 | €22,999 | €21,349 | -€1,650 | -7.2% |
| Other amounts payable | 47/48 | €22,999 | €21,349 | -€1,650 | -7.2% |
| Remuneration, social security and pensions | 62 | - | €275 | +€275 | |
| Other operating charges | 640/8 | €683 | €672 | -€11 | -1.6% |
| Gross operating margin | 9900 | -€14,693 | €7,008 | +€21,701 | |
| Operating profit (loss) | 9901 | -€15,376 | €6,060 | +€21,437 | |
| Financial charges | 65/66B | €254 | €300 | +€46 | +18.3% |
| Recurring financial charges | 65 | €254 | €300 | +€46 | +18.3% |
| Profit (loss) for the period before taxes | 9903 | -€15,630 | €5,760 | +€21,390 | |
| Income taxes | 67/77 | - | €3,831 | +€3,831 | |
| Profit (loss) for the period | 9904 | -€15,630 | €1,929 | +€17,559 | |
| Profit (loss) for the period to be appropriated | 9905 | -€15,630 | €1,929 | +€17,559 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.